Using Standards to Advance Cellular Therapy for Regenerative Medicine

Description:

Presenters describe how the FACT Common Standards can help advance cellular therapy in a variety of ways, including promoting patient safety, protecting the research environment, minimizing liabilities, and increasing support from funding organizations. Target audience includes members of academia, industry, clinical investigators with IND-approved trials, and clinical specialties exploring regenerative medicine applications. Members of the presentation panel representing a wide variety of perspectives include: - Ian McNiece, PhD Director, Cellular Therapy Laboratory at The University of Texas MD Anderson Cancer Center and Chair of the FACT Regenerative Medicine Task Force - Joanne Kurtzberg, MD Chief, Division of Pediatric Blood and Marrow Transplantation; Director, Carolinas Cord Blood Bank; and Director, DTRI Cell and Tissue Therapies Core at Duke University - Robert Simari, MD Chair of the NHLBI Cardiovascular Cell Therapy Research Network and Dean of Kansas University Medical Center School of Medicine - Marie Csete, MD, PhD Chief Scientific Officer of Huntington Medical Research Institutes This is a large file and will take several minutes to download. We encourage users to save the file to the computer before opening it to expedite download time, and to download and extract the file in advance of any planned meetings.